Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11491430 | PMC |
| http://dx.doi.org/10.3389/fopht.2024.1479755 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
"Triple and Plan" (TriPla) regimen for long lasting new generation intravitreal anti-VEGF.
Eur J Ophthalmol
January 2025
School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) medications are the primary treatment for neovascular age-related macular degeneration (nAMD). However, frequent administrations pose significant burdens on patients, healthcare providers, and systems. The treat-and-extend (T&E) regimen, which adjusts treatment intervals based on patient response, aims to reduce injection frequency while maintaining disease control.
View Article and Find Full Text PDFManagement of Large Submacular Hemorrhage Secondary to Neovascular Age-Related Macular Degeneration.
Ophthalmol Retina
January 2025
Philadelphia, Pennsylvania. Electronic address:
Editorial: X-linked retinoschisis: mechanisms and therapies.
Front Med (Lausanne)
December 2024
Department of Ophthalmology and Visual Sciences, The University of Iowa, Iowa City, IA, United States.
Editorial: Efficient artificial intelligence (AI) in ophthalmic imaging.
Front Med (Lausanne)
December 2024
Department of Eye and Vision Science, University of Liverpool, Liverpool, United Kingdom.
Rhegmatogenous retinal detachment: time to consider real prevention.
Graefes Arch Clin Exp Ophthalmol
December 2024
Helen Keller Foundation for Research and Education, Birmingham, AL, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!